Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-10-25 Purchase |
2023-10-27 4:15 pm |
Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director 10% Owner |
7,933,601 | $0.7568 | $6,004,149 | 14,992,741 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-27 Option Award |
2024-06-28 4:08 pm |
N/A 2034-06-27 |
Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-02-28 Option Award |
2024-02-28 5:29 pm |
N/A 2031-06-17 |
Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director |
4,411 | $0 | 4,411 (Direct) |
View |
| 2023-07-20 Option Award |
2023-07-21 4:10 pm |
N/A 2033-07-20 |
Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 4:12 pm |
N/A 2032-06-23 |
Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 4:01 pm |
N/A 2032-06-02 |
Entrada Therapeutics Inc. | TRDA | Nuechterlein Carole Director |
11,918 | $0 | 11,918 (Direct) |
View |
| 2021-10-28 Option Award |
2021-11-01 7:00 pm |
N/A 2031-10-28 |
Entrada Therapeutics Inc. | TRDA | Nuechterlein Carole Director |
23,552 | $0 | 23,522 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-17 5:09 pm |
N/A 2031-06-17 |
Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-10-20 Conversion |
2020-10-20 4:55 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director |
3,092,340 | $0 | 3,092,340 (Indirect) |
View |
Ownership |
2020-10-15 5:13 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director |
0 | $0 | 3,092,340 (Indirect) |
View |
| 2020-06-22 Option Award |
2020-06-23 07:07 am |
N/A 2030-06-21 |
Millendo Therapeutics Inc. | MLND | Nuechterlein Carole Director |
12,000 | $0 | 12,000 (Direct) |
View |